CMPS has 36-month beta value of 2.23. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CMPS is 85.15M, and currently, short sellers hold a 5.86% ratio of that float. The average trading volume of CMPS on May 16, 2025 was 986.85K shares.
CMPS) stock’s latest price update
The stock of Compass Pathways Plc ADR (NASDAQ: CMPS) has decreased by -0.22 when compared to last closing price of 3.95. Despite this, the company has experienced a 3.99% gain in its stock price over the last five trading sessions. zacks.com reported 2025-05-14 that COMPASS Pathways (CMPS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
CMPS’s Market Performance
Compass Pathways Plc ADR (CMPS) has seen a 3.99% rise in stock performance for the week, with a 31.81% gain in the past month and a -13.76% plunge in the past quarter. The volatility ratio for the week is 5.15%, and the volatility levels for the past 30 days are at 7.29% for CMPS. The simple moving average for the past 20 days is 2.11% for CMPS’s stock, with a -19.05% simple moving average for the past 200 days.
Analysts’ Opinion of CMPS
Many brokerage firms have already submitted their reports for CMPS stocks, with Stifel repeating the rating for CMPS by listing it as a “Buy.” The predicted price for CMPS in the upcoming period, according to Stifel is $11 based on the research report published on February 27, 2025 of the current year 2025.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see CMPS reach a price target of $23. The rating they have provided for CMPS stocks is “Outperform” according to the report published on July 23rd, 2024.
Morgan Stanley gave a rating of “Overweight” to CMPS, setting the target price at $30 in the report published on April 01st of the previous year.
CMPS Trading at 15.94% from the 50-Day Moving Average
After a stumble in the market that brought CMPS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.83% of loss for the given period.
Volatility was left at 7.29%, however, over the last 30 days, the volatility rate increased by 5.15%, as shares surge +26.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.24% lower at present.
During the last 5 trading sessions, CMPS rose by +4.75%, which changed the moving average for the period of 200-days by -47.83% in comparison to the 20-day moving average, which settled at $3.86. In addition, Compass Pathways Plc ADR saw 4.26% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CMPS starting from ATAI Life Sciences N.V., who sale 2,660,000 shares at the price of $6.05 back on Sep 26 ’24. After this action, ATAI Life Sciences N.V. now owns 6,905,774 shares of Compass Pathways Plc ADR, valued at $16,093,000 using the latest closing price.
Malievskaia Ekaterina, the 10% Owner of Compass Pathways Plc ADR, sale 8,900 shares at $7.91 during a trade that took place back on May 21 ’24, which means that Malievskaia Ekaterina is holding 3,931,687 shares at $70,379 based on the most recent closing price.
Stock Fundamentals for CMPS
The total capital return value is set at -0.65. Equity return is now at value -60.67, with -43.91 for asset returns.
Based on Compass Pathways Plc ADR (CMPS), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -13.74. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is -83.85.
Currently, EBITDA for the company is -178.21 million with net debt to EBITDA at 1.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.18.
Conclusion
To put it simply, Compass Pathways Plc ADR (CMPS) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
